Join
Live feed
·
INSIDERFilingvia Quantisnow
Fennec Pharmaceuticals Inc. logo

CHIEF FINANCIAL OFFICER Andrade Robert sold $883,500 worth of shares (75,000 units at $11.78) as part of a pre-agreed trading plan and exercised 21,928 shares at a strike of $5.10, decreasing direct ownership by 18% to 239,603 units (SEC Form 4) (tax withholding)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FENC (Fennec Pharmaceuticals Inc.) and more on Quantisnow.